» Articles » PMID: 33440735

The Acquisition of Colistin Resistance Is Associated to the Amplification of a Large Chromosomal Region in Kp52145

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2021 Jan 14
PMID 33440735
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

The appearance of carbapenem-resistant has increased the use of colistin as a last-resort antibiotic for treating infections by this pathogen. A consequence of its use has been the spread of colistin-resistant strains, in several cases carrying colistin resistance genes. In addition, when susceptible strains are confronted with colistin during treatment, mutation is a major cause of the acquisition of resistance. To analyze the mechanisms of resistance that might be selected during colistin treatment, an experimental evolution assay for 30 days using as a model the clinical kp52145 isolate in the presence of increasing amounts of colistin was performed. All evolved populations presented a decreased susceptibility to colistin, without showing cross-resistance to antibiotics belonging to other structural families. We did not find any common mutation in the evolved mutants, neither in already known genes, previously known to be associated with the resistance phenotype, nor in new ones. The only common genetic change observed in the strains that evolved in the presence of colistin was the amplification of a 34 Kb sequence, homologous to a prophage (Enterobacteria phage Fels-2). Our data support that gene amplification can be a driving force in the acquisition of colistin resistance by .

Citing Articles

High prevalence of polymyxin-heteroresistant carbapenem-resistant Klebsiella pneumoniae and its within-host evolution to resistance among critically ill scenarios.

Wang X, Meng T, Dai Y, Ou H, Wang M, Tang B Infection. 2024; 53(1):271-283.

PMID: 39143437 PMC: 11825540. DOI: 10.1007/s15010-024-02365-z.


Prevalence of Mutated Colistin-Resistant : A Systematic Review and Meta-Analysis.

Yusof N, Norazzman N, Hakim S, Mohd Azlan M, Amilda Anthony A, Mustafa F Trop Med Infect Dis. 2022; 7(12).

PMID: 36548669 PMC: 9782491. DOI: 10.3390/tropicalmed7120414.

References
1.
Munoz-Price L, Poirel L, Bonomo R, Schwaber M, Daikos G, Cormican M . Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases. Lancet Infect Dis. 2013; 13(9):785-96. PMC: 4673667. DOI: 10.1016/S1473-3099(13)70190-7. View

2.
Pontarollo R, Rioux C, Potter A . Cloning and characterization of bacteriophage-like DNA from Haemophilus somnus homologous to phages P2 and HP1. J Bacteriol. 1997; 179(6):1872-9. PMC: 178909. DOI: 10.1128/jb.179.6.1872-1879.1997. View

3.
Andrade F, Silva D, Rodrigues A, Pina-Vaz C . Colistin Update on Its Mechanism of Action and Resistance, Present and Future Challenges. Microorganisms. 2020; 8(11). PMC: 7692639. DOI: 10.3390/microorganisms8111716. View

4.
Choi Y, Chan A . PROVEAN web server: a tool to predict the functional effect of amino acid substitutions and indels. Bioinformatics. 2015; 31(16):2745-7. PMC: 4528627. DOI: 10.1093/bioinformatics/btv195. View

5.
Padilla E, Llobet E, Domenech-Sanchez A, Martinez-Martinez L, Bengoechea J, Alberti S . Klebsiella pneumoniae AcrAB efflux pump contributes to antimicrobial resistance and virulence. Antimicrob Agents Chemother. 2009; 54(1):177-83. PMC: 2798511. DOI: 10.1128/AAC.00715-09. View